Poseida Therapeutics

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative gene therapies and cell therapies for cancer and rare diseases. They leverage proprietary technologies such as the piggyBac DNA Modification System and Cas-CLOVER gene editing to create more effective and safer treatments. Founded in 2015, Poseida has made significant strides in advancing its pipeline, including multiple CAR-T therapies currently in clinical trials. The company generates revenue through partnerships, collaborations, and licensing agreements with other biotech firms and research institutions.

Recent Posts by Poseida Therapeutics

1-12 of 12